MK-0752 alone can induce ovarian cancer cell cycle arrest and apoptosis.
Sequential combination of cisplatin prior to MK-0752 significantly inhibits the tumor growth in vitro and in vivo.
Sequential combination of cisplatin prior to MK-0752 may make benefits for ovarian cancer treatment.